|
Pfizer returns asthma drug development to Rigel
Forbes Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage company said … Rigel says Pfizer returns asthma therapy rights Rigel Assumes Development Responsibility for Inhaled Asthma Therapy Pfizer returns allergic asthma drug to Rigel |
View full post on asthma – Google News
